Evidence map›Paper›PMID 42409772›Full record

ArticleCell death & disease2026

Phase separation drives NLRP3 inflammasome activation independently of Golgi localization.

Yuansen Zhu, Chenchao Wei, Xiang Yin, Bolong Lin, Xiaqiong Wang, Hongbin He, Wei Jiang, Rongbin Zhou

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuansen ZhuState Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.ORCID http://orcid.org/0009-0006-0923-7663
Chenchao WeiState Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Xiang YinState Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Bolong LinState Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Xiaqiong WangState Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.ORCID http://orcid.org/0000-0001-9519-1732
Hongbin HeState Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. hhb123@ustc.edu.cn.
Wei JiangState Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. ustcjw@ustc.edu.cn.ORCID http://orcid.org/0000-0001-8327-3079
Rongbin ZhouState Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. zrb1980@ustc.edu.cn.ORCID http://orcid.org/0000-0002-3351-6420

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The NLRP3 inflammasome plays a pivotal role in sterile inflammation and various diseases, yet the mechanisms underlying its activation remain elusive. Previous studies have implicated both NLRP3 Golgi localization and palmitoylation-mediated phase separation in its activation; however, mutations in palmitoylation sites or the FISNA domain's intrinsically disordered region (IDR) concurrently disrupt both processes, hindering delineation of their individual contributions to inflammasome activation. Here, we show that NLRP3 exhibits phase separation and Golgi localization simultaneously during inflammasome activation. The polybasic region and FISNA IDR each mediate both processes, whereas lipid-binding motif deletion abolishes Golgi localization without compromising phase separation or inflammasome activity. Conversely, the C-terminal IDR is essential for phase separation and inflammasome activity but dispensable for Golgi localization. By mechanistically uncoupling these processes, our findings establish that phase separation drives NLRP3 activation independently of Golgi localization, thus redefining the spatial and biophysical paradigm of inflammasome assembly.

Indexed as

Golgi ApparatusInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinAnimalsHEK293 CellsHumansPhase SeparationInflammasomesNLR Family, Pyrin Domain-Containing 3 Protein

Identifiers

PMID42409772
PMCPMC13616974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.